ATE66148T1 - Verfahren zur herstellung von bestaendigen pharmazeutischen zusammensetzungen von prostaglandin-e-derivaten und/oder ihren 15rformen. - Google Patents

Verfahren zur herstellung von bestaendigen pharmazeutischen zusammensetzungen von prostaglandin-e-derivaten und/oder ihren 15rformen.

Info

Publication number
ATE66148T1
ATE66148T1 AT85115016T AT85115016T ATE66148T1 AT E66148 T1 ATE66148 T1 AT E66148T1 AT 85115016 T AT85115016 T AT 85115016T AT 85115016 T AT85115016 T AT 85115016T AT E66148 T1 ATE66148 T1 AT E66148T1
Authority
AT
Austria
Prior art keywords
prostaglandin
forms
preparation
stable pharmaceutical
derivatives
Prior art date
Application number
AT85115016T
Other languages
English (en)
Inventor
Kohtaro Miwa
Kazuo Igusa
Toshichika Ogasawara
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE66148T1 publication Critical patent/ATE66148T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT85115016T 1984-11-30 1985-11-27 Verfahren zur herstellung von bestaendigen pharmazeutischen zusammensetzungen von prostaglandin-e-derivaten und/oder ihren 15rformen. ATE66148T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25382584 1984-11-30
EP85115016A EP0183237B1 (de) 1984-11-30 1985-11-27 Verfahren zur Herstellung von beständigen pharmazeutischen Zusammensetzungen von Prostaglandin-E-Derivaten und/oder ihren 15R-Formen

Publications (1)

Publication Number Publication Date
ATE66148T1 true ATE66148T1 (de) 1991-08-15

Family

ID=17256655

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85115016T ATE66148T1 (de) 1984-11-30 1985-11-27 Verfahren zur herstellung von bestaendigen pharmazeutischen zusammensetzungen von prostaglandin-e-derivaten und/oder ihren 15rformen.

Country Status (7)

Country Link
US (1) US4871772A (de)
EP (1) EP0183237B1 (de)
JP (1) JPS61267552A (de)
KR (1) KR920007569B1 (de)
AT (1) ATE66148T1 (de)
CA (1) CA1256029A (de)
DE (1) DE3583794D1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0707333B8 (pt) * 2006-01-24 2021-05-25 R Tech Ueno Ltd composição farmacêutica que compreende um composto bicíclico, método de estabilização do composto bicíclico e formulação de cápsula de gelatina mole
CN101808623B (zh) 2007-07-19 2013-08-14 株式会社·R-技术上野 包含11-脱氧-前列腺素化合物的药物组合物和使该化合物稳定化的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3450821A (en) * 1967-03-02 1969-06-17 Hoffmann La Roche Stable compositions containing eicosatetrayn - (5,8,11,14) - oic-(1) acid and derivatives thereof
US3880906A (en) * 1971-05-24 1975-04-29 Alza Corp Novel compounds related to prostaglandins
US4045577A (en) * 1971-06-17 1977-08-30 Alza Corporation Valuable medicinial prostaglandin compounds prepared from material isolated from the sea
JPS5438460B2 (de) * 1972-01-28 1979-11-21
US3903297A (en) * 1973-11-01 1975-09-02 Upjohn Co Method of treatment and prophylaxis of gastric hypersecretion and gastric and duodenal ulcers using prostaglandin analogs
US4092425A (en) * 1977-08-08 1978-05-30 The Upjohn Company Restoration of interferon response
US4301175A (en) * 1980-12-29 1981-11-17 The Upjohn Company E-Type prostaglandin compositions
US4335097A (en) * 1981-01-15 1982-06-15 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. Stabilized, prostaglandin-containing tablets with controlled rate of solubility, for local use and process for the preparation thereof
JPH0818989B2 (ja) * 1984-01-12 1996-02-28 株式会社ミドリ十字 脂肪乳剤中のプロスタグランジンの安定化方法

Also Published As

Publication number Publication date
DE3583794D1 (de) 1991-09-19
KR860003831A (ko) 1986-06-13
KR920007569B1 (ko) 1992-09-07
EP0183237A2 (de) 1986-06-04
US4871772A (en) 1989-10-03
JPS61267552A (ja) 1986-11-27
EP0183237B1 (de) 1991-08-14
EP0183237A3 (en) 1986-08-13
CA1256029A (en) 1989-06-20

Similar Documents

Publication Publication Date Title
IL77396A (en) Pharmaceutical compositions containing bicyclic heteroarylpiperazine derivatives,certain such novel compounds and their preparation
NO854833L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tricykloforbindelser.
OA06428A (fr) Composés de 2-penem, procédé de préparation et composition pharmaceutique obtenue.
FR2392971A1 (fr) Derives de l'acide prostanoique, leur preparation et medicament contenant ces substances
UA45942A (uk) 1,3-оксатіолан, його похідні, спосіб (варіанти) його одержання та фармацевтична композиція
ATE15142T1 (de) Antithrombotikum auf basis von polysacchariden, verfahren zur dessen herstellung und medizinale zusammensetzungen.
FR2411839B1 (fr) Derives de l'acide cephalosporanique, procedes pour leur preparation et composition pharmaceutique les contenant
ZA796356B (en) New hydroxypropyl-triazole compounds, their production and their medicinal use
FR2343736A1 (fr) Nouveaux derives de sulfonamide, leur procede de preparation ainsi que les compositions therapeutiques les contenant
DE3856158D1 (de) Verfahren zur Herstellung von Zwischenverbindungen verwendbar in der Herstellung von 2',2'-Difluoronucleosiden
FR2361400A1 (fr) Nouveaux analogues sulfures de penicillines et de cephalosporines, leur procede de preparation et composition pharmaceutique les contenant
ATE26213T1 (de) Aeusserlich anzuwendende arzneimittelzubereitung enthaltend adenosin zur behandlung von herpes.
ATE33022T1 (de) S-(carbamoyl-phenylselenyl)-derivate von mercaptanen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
FR2343730A1 (fr) Derives d'acide amidinoformique ou d'acide amidinosulfinique, leur preparation et compositions pharmaceutiques les contenant
ATE37369T1 (de) Eine thiazinverbindung, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3583794D1 (de) Verfahren zur herstellung von bestaendigen pharmazeutischen zusammensetzungen von prostaglandin-e-derivaten und/oder ihren 15r-formen.
BE830577A (fr) Derives actifs d'acide acetique, compositions therapeutiques les contenant ainsi que les procedes de preparation de ces derives et compositions
OA08165A (fr) Nouveaux dérivés thiosulfonates, leur procédé de préparation ainsi que les compositions pharmaceutiques les contenant.
FR2440353A1 (fr) Nouveaux arylethanols, leurs procedes d'obtention et leur emploi comme medicament
ES2040226T3 (es) Procedimiento para preparar nuevos tetrahidro-benzotiazoles.
FR2335222A1 (fr) Derives etherifies de l'acide clavulanique, leur preparation et compositions therapeutiques en contenant
AT344885B (de) Verfahren zur herstellung von 18-arabinosyl-2-n-butyl-3,7,11,15,19,21,23,25,27,37-dekahydroxy-4,16,32,34,36-pentamethyl-tetrakonta-16,32-dien-35-o-lacton-40-guanidiniumsulfat(debrycin) enthaltenden pharmazeutischen praeparaten
GB1498919A (en) Furanose-o-pyridylcarboxylic acid esters
FR2368490A1 (fr) Nouveaux derives de l'acide clavulanique, leur preparation et compositions pharmaceutiques en contenant
IL59768A (en) Prostaglandin derivatives of the 6-keto-pge1 series,process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee